Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
China
Biotech
Hansoh, Chugai ink separate and lucrative licensing agreements
A pair of licensing deals has emerged from Hansoh Pharma and Rani Therapeutics that together represent billions of dollars in potential payouts.
Fraiser Kansteiner
Oct 17, 2025 11:04am
Kite puts $1.64B on the line for Pregene's in vivo CAR-Ts
Oct 16, 2025 4:56pm
'Let that one go': Nkarta CEO urges US gov to drop China regs
Oct 16, 2025 2:00pm
Dianthus offers up to $1B for China biotech’s autoimmune asset
Oct 16, 2025 10:57am
Expedition resupplies for ph. 2 COPD voyage with $165M series A
Oct 9, 2025 9:50am
Novo vs. KBP Chapter 3: Fraud or due diligence slipup?
Oct 2, 2025 3:00am
